MarketPulse

channel stuffing

14 articles
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

ADMA Biologics Faces Securities Investigation Over Channel Stuffing Allegations

The Rosen Law Firm investigates ADMA Biologics for alleged channel stuffing following a Culper Research report that triggered a 16.6% stock decline.
ADMAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Block & Leviton Llp

ADMA Biologics Plunges 24% After Withdrawing Guidance; Law Firm Eyes Securities Claims

ADMA Biologics shares fell 24% after withdrawing guidance amid channel stuffing allegations. Block & Leviton investigates potential securities violations affecting multiple companies.
WGSWGSWWPRIMADMAsecurities fraudstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

ADMA Biologics Faces Securities Investigation Over Channel Stuffing Allegations

ADMA Biologics stock plunged 16.6% after short seller allegations of channel stuffing. Law firm investigates potential securities fraud claims.
ADMAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

ADMA Biologics Faces Securities Fraud Investigation Amid Channel Stuffing Allegations

Pomerantz Law Firm investigates $ADMA for potential securities fraud after Culper Research alleges channel stuffing, with stock plunging 30% in two days.
ADMAsecurities fraudstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

ADMA Biologics Faces Securities Investigation Over Channel Stuffing Allegations

ADMA Biologics faces securities investigation for alleged channel stuffing. Stock fell 16.6% after allegations; class action lawsuit being prepared.
ADMAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

ADMA Biologics Stock Plummets on Channel Stuffing Allegations; Law Firm Launches Investigation

Rosen Law Firm investigates ADMA Biologics for allegedly misleading investors. Stock fell 16.6% after short seller Culper Research alleged channel stuffing to inflate revenue.
ADMAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

ADMA Biologics Stock Plunges 16.6% After Channel Stuffing Allegations

ADMA Biologics ($ADMA) stock crashed 16.6% following channel stuffing allegations. Rosen Law Firm launches investigation into securities fraud claims.
ADMAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Lowey Dannenberg, P.C.

ADMA Biologics Under SEC Investigation for Alleged Channel Stuffing Scheme

ADMA Biologics faces SEC investigation for allegedly inflating 2025 revenue growth from -3% actual to +20% reported through channel stuffing practices with distributors.
ADMAsecurities fraudinvestor losses
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

ADMA Biologics Faces Short-Seller Allegations of Revenue Inflation

Law firm investigates $ADMA over channel stuffing claims. Stock plummets 16.63% after short report alleges actual 2025 revenues declined 3% despite reported 20% growth.
ADMAsecurities investigationstock price decline
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

ADMA Biologics Faces Securities Investigation Over Revenue Growth Allegations

ADMA Biologics faces securities fraud investigation after short report alleges $20% growth claims masked 3% actual revenue decline, triggering 30% stock collapse.
ADMAsecurities fraudstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Bleichmar Fonti & Auld Llp

ADMA Biologics Faces Securities Fraud Probe Over Channel Stuffing Claims

ADMA Biologics under fraud investigation after Culper Research alleged channel stuffing masked -3% actual revenue decline reported as +20% growth, causing 29% stock collapse.
ADMAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

ADMA Biologics Under Investigation for Alleged Channel Stuffing and Securities Violations

Law firm Kirby McInerney investigates $ADMA for potential securities violations. Culper Research alleges channel stuffing and undisclosed related-party distribution practices inflated 2025 growth.
ADMAsecurities fraudclass action investigation
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

ADMA Biologics Plunges 16% as Short Seller Alleges Channel Stuffing Scheme

ADMA Biologics shares crashed 16% after short seller accused the company of inflating revenues through improper rebates and extended payment terms to distributors.
ADMAsecurities fraudbiopharmaceutical
BenzingaBenzinga··Glancy Prongay Wolke & Rotter Llp

ADMA Biologics Faces Securities Fraud Probe Over Channel Stuffing Allegations

ADMA Biologics faces securities fraud investigation for alleged channel stuffing, resulting in 29.1% stock decline to $9.63 per share.
ADMAsecurities fraudstock decline